Changes to the Code
H.R. 6321 · Lung Cancer Medicare Access to Precise Testing Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 1395x Definitions
3 changes the bill asks for here, 2 carried out
- Not carried out:
in subparagraph (JJ), by adding
and
at the end; andThe law already reads this way: § 1395x(s)(2)(JJ) already has “and”.
Technical detail
already reads “and” at that place in /us/usc/t42/s1395x/s/2/JJ - Carried out:
by adding at the end the following new subparagraph:
(KK) lung cancer biomarker testing (as defined in subsection (nnn));; and
The section already has a provision under this letter or number, so it would have two.
- Carried out:
by adding at the end the following new subsection:
(nnn) Lung cancer biomarker testing.— The term “lung cancer biomarker testing” means a test furnished on or after January 1, 2027, to an individual diagnosed with lung cancer for the identification of 1 or more specific biomarkers (such as genes, proteins, or other molecules) …
The section already has a provision under this letter or number, so it would have two.
This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.
1 of the 3 changes this bill asks for here is already in the law as it stands, and was not made a second time. The bill, or another making the same changes, has probably become law since.
§ 1395x(s)Medical and other health services(2)–(4)
Start of § 1395x to (s)(2)(II) unchanged
| Where | Mark | Text |
|---|---|---|
| (2)(JJ) | (JJ) | |
| lymphedema compression treatment items (as defined in subsection (mmm)); and | ||
| (2)(KK) | (KK) | |
| multi-cancer early detection screening tests (as defined in subsection (nnn)); | ||
| (2)(KK) | (KK) [inserted: ] | |
| [inserted: lung cancer biomarker testing (as defined in subsection (nnn));] | ||
| (3) | (3) | |
| diagnostic X-ray tests (including tests under the supervision of a physician, furnished in a place of residence used as the patient’s home, if the performance of such tests meets such conditions relating to health and safety as the Secretary may find necessary and including diagnostic mammography if conducted by a facility that has a certificate (or provisional certificate) issued under section 354 of the Public Health Service Act [42 U.S.C. 263b]), diagnostic laboratory tests, and other diagnostic tests; | ||
| (4) | (4) | |
| X-ray, radium, and radioactive isotope therapy, including materials and services of technicians; |
§ 1395x(nnn)–(nnn)
(s)(5)–(nnn)(1) unchanged
| Where | Mark | Text |
|---|---|---|
| (nnn)(1)(C)(ii) | (ii) | |
| appropriate for individuals entitled to benefits under part A or enrolled under part B. | ||
| (nnn)(2) | (2) NCD process | |
| In making determinations under paragraph (1)(C) regarding the coverage of a new test, the Secretary shall use the process for making national coverage determinations (as defined in section 1395ff(f)(1)(B) of this title) under this subchapter. | ||
| (nnn) | (nnn) [inserted: Lung cancer biomarker testing.—] | |
| [inserted: The term “lung cancer biomarker testing” means a test furnished on or after January 1, 2027, to an individual diagnosed with lung cancer for the identification of 1 or more specific biomarkers (such as genes, proteins, or other molecules) based on the analysis of such individual’s tissue, blood, or bodily fluids.] |
42 U.S.C. § 1395y Exclusions from coverage and medicare as secondary payer
2 changes the bill asks for here, 1 carried out
- Not carried out:
by striking
and (HH)
and inserting(HH)
; and“and (HH)” isn't in § 1395y(a)(1) in the Code as we have it. The law may have changed since the bill was drafted.
Technical detail
“and (HH)” not found in /us/usc/t42/s1395y/a/1 - Carried out:
by inserting
, and (II) with respect to lung cancer biomarker testing (as defined in section 1861(nnn)), the amount paid shall be 100 percent of the reasonable charges for such testing
before the semicolon at the end.
§ 1395y(a)Items or services specifically excluded(1)–(3)
Start of § 1395y to (a)(1)(N) unchanged
| Where | Mark | Text |
|---|---|---|
| (1)(O) | (O) | |
| in the case of kidney disease education services (as defined in paragraph (1) of section 1395x(ggg) of this title), which are furnished in excess of the number of sessions covered under paragraph (4) of such section, and | ||
| (1)(P) | (P) | |
| in the case of personalized prevention plan services (as defined in section 1395x(hhh)(1) of this title), which are performed more frequently than is covered under such section; | ||
| in the case of personalized prevention plan services (as defined in section 1395x(hhh)(1) of this title), which are performed more frequently than is covered under such section[inserted: , and (II) with respect to lung cancer biomarker testing (as defined in section 1861(nnn)), the amount paid shall be 100 percent of the reasonable charges for such testing]; | ||
| (2) | (2) | |
| for which the individual furnished such items or services has no legal obligation to pay, and which no other person (by reason of such individual’s membership in a prepayment plan or otherwise) has a legal obligation to provide or pay for, except in the case of Federally qualified health center services; | ||
| (3) | (3) | |
| which are paid for directly or indirectly by a governmental entity (other than under this chapter and other than under a health benefits or insurance plan established for employees of such an entity), except in the case of rural health clinic services, as defined in section 1395x(aa)(1) of this title, in the case of Federally qualified health center services, as defined in section 1395x(aa)(3) of this title, in the case of services for which payment may be made under section 1395qq(e) of this title, and in such other cases as the Secretary may specify; |
Rest of § 1395y unchanged